HealthNews

eha Impact Ventures secures $1.9m grant to support African women entrepreneurs

A gender-lens impact investing enterprise, eha Impact Ventures (EIV), has received a $1.9 million grant from eHealth Africa (eHA), a global health organisation, to support women entrepreneurs in Africa.

This grant marks a major milestone in EIV’s effort to provide catalytic capital for its portfolio and potential investments, says a press statement issued by eha Impact Ventures.

It also addresses the $42 billion funding gap for women entrepreneurs in Africa, positions female founders to access better funding opportunities, and prioritises women’s financial needs.

According to the CEO, Evelyn Castle, “the donation validates the recognised potential and untapped talent of women entrepreneurs across the continent.”

She stressed that EIV would use the donation to create a supportive entrepreneurial ecosystem through increased funding, mentorships, and training programmes.

“We will support women entrepreneurs to grow their businesses, create jobs, and enhance African healthcare systems,” noted Evelyn Castle.

Recognising women’s vital role in building strong health systems, Atef Fawaz, the CEO of eHealth Africa, stated: “We acknowledge the profound impact women have in strengthening healthcare systems, aligning with our vision at eHealth Africa.”

A female board executive at eHealth Africa, My Le, added that “these donations come at a crucial time as women struggle to meet health and economic demands. We believe the funds will help bridge fiscal gaps for women and other vulnerable groups, leading to healthier lives.”

EIV is a philanthropic impact investing enterprise that supports early-stage, high-impact, women-led businesses in Africa. Unlike traditional business financing, EIV offers flexible and innovative funding options paired with high-quality, local, shared business resources to ensure business growth and success.

Related Posts

Leave a Comment

This News Site uses cookies to improve reading experience. We assume this is OK but if not, please do opt-out. Accept Read More